NCT02992080View on ClinicalTrials.gov

Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 12, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Cystic Fibrosis
Interventions
OTHER

miRNAs isolation from blood samples of patients and control

Blood sample collection in specific PAXGene tubes

Trial Locations (2)

34295

Montpellier University Hospital, Montpellier

75015

Necker Hospital, Paris

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02992080 - Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis | Biotech Hunter | Biotech Hunter